No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Recent Funding - Zenith CC

NBB, I didn't realize that Hepa has shares in ZCC.

Do you know how many share of ZCC they own?

Thanks.

Toinv

Share
New Message
Please login to post a reply